openPR Logo
Press release

Irritable Bowel Syndrome Treatment Market Grow Like Never Before | Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals

11-18-2020 07:02 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market

The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms associated with the condition, as the causes behind occurrence of irritable bowel syndrome are yet to be established. Patients suffering from irritable bowel syndrome show symptoms such as abdominal pain, diarrhea, and constipation. Long-term and recurring presence of these symptoms signals the possibility of irritable bowel syndrome. The treatment depends on severity of these symptoms, which are distinguished as mild, moderate, and severe. Mild symptoms do not significantly affect the quality of life.

Get a sample pages of this report@: https://www.coherentmarketinsights.com/insight/request-sample/549

However, severe symptoms are more frequent and intense and need to be addressed. The disease is often linked with dietary, lifestyle factors, and stress, which can be controlled by managing stress levels, diet, and exercise. Severe symptoms need to be treated through medication prescribed by physicians. Two major therapy options are available for the treatment of IBS, namely, medical or drug therapy and nutritional therapy. Medical therapy includes drugs for relieving the symptoms and nutritional therapy by using fibers and probiotics or prebiotics depending on the situation.

Market Dynamics

The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market.

Need a discount?

Note: *The discount is offered on the Standard Price of the report.

Get Your Copy at a Discounted Rate!!! Limited Time Offer!!! @ https://www.coherentmarketinsights.com/insight/request-discount/506  

This report segments the global irritable bowel syndrome treatment market on the basis of drug type, medical condition, and distribution channel. On the basis of drug type, the global irritable bowel syndrome treatment market is segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, Ramosetron Hydrochloride and others. Medical conditions of irritable bowel syndrome includes IBS-constipation and IBS-diarrhea. Irritable bowel syndrome treatment market is segmented by distribution channel as hospital pharmacies, online pharmacies and retail pharmacies.

Global Irritable Bowel Syndrome Treatment Market, By Drug Type:
Lubiprostone
Linaclotide
Eluxadoline
Rifaximin
Ramosetron Hydrochloride
Others
Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:
IBS-Constipation
IBS-Diarrhea
Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Some major players operating in the irritable bowel syndrome treatment market are Abbott Laboratories, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., and Ironwood Pharmaceuticals, Inc.

Contact us for any query or to get a personalized report@: https://www.coherentmarketinsights.com/insight/request-customization/506

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Irritable Bowel Syndrome Treatment Market Grow Like Never Before | Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals here

News-ID: 2189328 • Views: 217

More Releases from Coherent Market Insights

Flash-based Array Market Insights Into the Competitive Scenario of the Most Grow …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗙𝗹𝗮𝘀𝗵-𝗯𝗮𝘀𝗲𝗱 𝗔𝗿𝗿𝗮𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗲𝘅𝗵𝗶𝗯𝗶𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟭𝟴.𝟬% 𝗗𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁𝗲𝗱 𝗽𝗲𝗿𝗶𝗼𝗱 (𝟮𝟬𝟭𝟵-𝟮𝟬𝟮𝟳) Summary of the Report - CMI's latest report, global "Flash-based Array Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Tintri, Inc., Hitachi Data Systems Corporation, IBM Corporation, Tegile Systems, Inc., Oracle Corporation, Kaminario
Flash-based Array Market Insights Into the Competitive Scenario of the Most Grow …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗙𝗹𝗮𝘀𝗵-𝗯𝗮𝘀𝗲𝗱 𝗔𝗿𝗿𝗮𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗲𝘅𝗵𝗶𝗯𝗶𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟭𝟴.𝟬% 𝗗𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁𝗲𝗱 𝗽𝗲𝗿𝗶𝗼𝗱 (𝟮𝟬𝟭𝟵-𝟮𝟬𝟮𝟳) Summary of the Report - CMI's latest report, global "Flash-based Array Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Tintri, Inc., Hitachi Data Systems Corporation, IBM Corporation, Tegile Systems, Inc., Oracle Corporation, Kaminario
Consumer Network Attached Storage (NAS) Market 2022 Global Competition by Opport …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗖𝗼𝗻𝘀𝘂𝗺𝗲𝗿 𝗡𝗲𝘁𝘄𝗼𝗿𝗸 𝗔𝘁𝘁𝗮𝗰𝗵𝗲𝗱 𝗦𝘁𝗼𝗿𝗮𝗴𝗲 (𝗡𝗔𝗦) 𝗠𝗮𝗿𝗸𝗲𝘁 𝗶𝘀 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝘁𝗼 𝗲𝘅𝗵𝗶𝗯𝗶𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟵.𝟱% 𝗗𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝗽𝗲𝗿𝗶𝗼𝗱 (𝟮𝟬𝟭𝟵-𝟮𝟬𝟮𝟳) Summary of the Report - CMI's latest report, global "Consumer Network Attached Storage (NAS) Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - D-Link Corporation, Seagate Technology Public Limited Company, Synology
Automated Fare Collection System Market Investment Activity From Established Com …
Global Automated Fare Collection System Market is expected to exhibit a CAGR of 11.1% during the forecast period (2019-2027), as highlighted in a report published by Coherent Market Insights Summary of the Report - CMI's latest report, global "Automated Fare Collection System Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Cubic

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business